4-Bromo-5-fluoro-2-methoxypyridine

Catalog No. :
ACZBVK730
CAS No. :
884495-00-5
Molecular Formula :
C6H5BrFNO
Molecular Weight :
206.01

IUPAC Name:4-bromo-5-fluoro-2-methoxypyridine

4-Bromo-5-fluoro-2-methoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$54.00Login to see priceIn stockIn stock
1g97%$188.00Login to see priceIn stockIn stock
5g97%$936.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-5-fluoro-2-methoxypyridine
IUPAC Name4-bromo-5-fluoro-2-methoxypyridine
MDL No.MFCD05662409
Molecular FormulaC6H5BrFNO
Molecular Weight206.01
SMILESCOC1=NC=C(F)C(Br)=C1
InChI KeyUBOXAHNHAAPUKF-UHFFFAOYSA-N
SynonymDS-12974 | J-514763 | FT-0692421 | MFCD05662409 | 2-Methoxy-4-Bromo-5-Fluoropyridine | 4-bromo-5-fluoro-2-methoxypyridine | UBOXAHNHAAPUKF-UHFFFAOYSA-N | AC-33409 | F12224 | EN300-226640 | AKOS015891888 | DTXSID90660531 | CS-0159569 | SY260137 | AMY6265 |
CAS No.884495-00-5
PubChem CID44754825

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZBVK730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACPTUV567 route compound structure diagram
    ACPTUV5671349718-16-6 In Stock
  4. Then
  5. ACZBVK730 route product structure diagram
    ACZBVK730884495-00-5 In Stock
Inquiry

2. ACZBVK730 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACPTUV567 route compound structure diagram
    ACPTUV5671349718-16-6 In Stock
  4. Then
  5. ACZBVK730 route product structure diagram
    ACZBVK730884495-00-5 In Stock
Inquiry

Comments (0)